Proteomics

Cancer research and proteomics-focused groups team up on early cancer diagnosis

Published in Cancer Weekly, October 11th, 2005

Invitrogen Corporation (IVGN), a provider of life science technologies for disease research and drug discovery, and the Fred Hutchinson Cancer Research Center announced they have entered into a multi-year collaborative research program for the development of diagnostics and screening tools for cancer.

Under the collaboration, Invitrogen will use its expertise with the human proteome and proteomics-based approaches in combination with investigations by the lab of Sam Hanash, MD, PhD, at the Hutchinson Center.

Invitrogen will utilize a variety of its proteomics technologies including its ProtoArray protein microarrays and protein and antibody...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2005-10-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry